BYON4228 + Pembrolizumab clinical trials

A Dose Escalation and Expansion Trial With BYON4228 Alone and in Combination in Patients With Advanced or Metastatic Solid Tumors

This study is testing a new drug, BYON4228, sometimes with another drug called pembrolizumab, for people with advanced solid tumours. It aims to find the right dose and see how safe and effective this treatment is.